Related Experiment Video
Updated: Jul 15, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Nuclear structure as a source of cancer specific biomarkers
Eddy S Leman1, Robert H Getzenberg
1The Johns Hopkins University School of Medicine, Department of Urology, 600 N. Wolfe Street, Marburg 121, Baltimore, Maryland 21287, USA.
New cancer biomarkers derived from the nuclear matrix show promise for early detection and prognosis. These molecular markers can identify specific cancers like prostate, colon, and bladder through blood or urine tests.
Area of Science:
- Oncology
- Proteomics
- Biomarker Discovery
Background:
- Current cancer diagnosis relies heavily on microscopic cell examination, lacking sufficient specific biomarkers.
- The nuclear matrix, a key cellular structure, contains proteins relevant to cancer development.
Purpose of the Study:
- To identify novel cancer biomarkers from the nuclear matrix.
- To develop diagnostic assays for early cancer detection and prognosis.
Main Methods:
- Proteomic analysis of nuclear matrix proteins.
- Development of assays using blood and urine samples.
Main Results:
- Identified cancer-specific biomarkers for prostate, colon, and bladder cancers.
- Developed assays capable of detecting these cancer types.
Conclusions:
- Nuclear matrix proteomics offers a promising avenue for cancer biomarker discovery.
- The identified biomarkers have potential for clinical diagnostic assays, therapeutic targeting, and imaging.
Related Concept Videos
The Nucleolus
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Additional Subnuclear Structures
The nucleus contains many membrane-less subnuclear organelles or nuclear bodies, such as nucleoli, Cajal bodies, speckles, paraspeckles, etc. These nuclear...
Isotopes and Radioisotopes
An isotope containing more...
Nuclear Localization Signals and Import

